Mast cells are involved in the pathogenesis of indomethacin-induced rat enteritis

Journal of Gastroenterology

Volumn 44, Issue SUPPL. 19, 2009, Pages 35-39

  Okayama, Tetsuya ^a   Yoshida, Norimasa ^a   Uchiyama, Kazuhiko ^a   Takagi, Tomohisa ^a   Ichikawa, Hiroshi ^a   Yoshikawa, Toshikazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Enteritiss mall intestine; Indomethacin; Mast cell; NSAID

Indexed keywords

CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT 1; INDOMETACIN; MYELOPEROXIDASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENTERITIS; INTESTINE ULCER; LIPID PEROXIDATION; MALE; MAST CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RAT; SMALL INTESTINE DISEASE; SMALL INTESTINE MUCOSA;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMOKINE CXCL1; ENTERITIS; INDOMETHACIN; INTESTINAL MUCOSA; LIPID PEROXIDATION; MALE; MAST CELLS; NEUTROPHILS; PEROXIDASE; RATS; RATS, MUTANT STRAINS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 58849139265     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-008-2267-5     Document Type: Article

References (26)

1. Robert A, Asano T. Resistance of germfree rats to indomethacin-induced intestinal lesions. Prostaglandins 1977;14:333-341.
2. Fang WF, Broughton A, Jacobson ED. Indomethacin-induced intestinal inflammation. Am J Dig Dis 1977;22:749-760.
3. Bjarnason I, Zanelli G, Smith T, Prouse P, Williams P, Smethurst P, et al. Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans. Gastroenterology 1987;93:480-489.
4. Whittle BJ. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology 1981;80:94-98.
5. Weissenborn U, Maedge S, Buettner D, Sewing KF. Indometacin-induced gastrointestinal lesions in relation to tissue concentration, food intake and bacterial invasion in the rat. Pharmacology 1985;30:32-39.
6. 2. Gastroenterology 1987;93:744-752.
7. Yamada T, Deitch E, Specian RD, Perry MA, Sartor RB, Grisham MB. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation 1993;17:641-662.
8. Whittle BJ, Laszlo F, Evans SM, Moncada S. Induction of nitric oxide synthase and microvascular injury in the rat jejunum provoked by indomethacin. Br J Pharmacol 1995;116:2286-2290.
9. Basivireddy J, Jacob M, Ramamoorthy P, Pulimood AB, Balasubramanian KA. Indomethacin-induced free radicalmediated changes in the intestinal brush border membranes. Biochem Pharmacol 2003;65:683-695.
10. Ruh J, Vogel F, Schmidt E. In vivo assessment of villous microcirculation in the rat small intestine in indomethacin-induced inflammation: Role of mast-cell stabilizer Ketotifen. Acta Physiol Scand 2000;170:137-143.
11. Konaka A, Nishijima M, Tanaka A, Kunikata T, Kato S, Takeuchi K. Nitric oxide, superoxide radicals and mast cells in pathogenesis of indomethacin-induced small intestinal lesions in rats. J Physiol Pharmacol 1999;50:25-38.
12. Antoon JS, Perry MA. Role of neutrophils and mast cells in acute indomethacin-induced small bowel injury in the rat. J Gastroenterol 1997;32:747-757.
13. Martinolle JP, Garcia-Villar R, More J, Bueno L. Evidence for mast cell, leukotriene and nitric oxide involvement in the regulation of the adrenoceptor number of inflamed small intestine in guinea pigs. Neurogastroenterol Motil 1995;7:187-195.
14. Konaka A, Kato S, Tanaka A, Kunikata T, Korolkiewicz R, Takeuchi K. Roles of enterobacteria, nitric oxide and neutrophil in pathogenesis of indomethacin-induced small intestinal lesions in rats. Pharmacol Res 1999;40:517-524.
15. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-358.
16. Grisham MB, Hernandez LA, Granger DN. Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol 1986;251:G567-G574.
17. Sivalingam N, Hanumantharaya R, Faith M, Basivireddy J, Balasubramanian KA, Jacob M. URCUMIN reduces indomethacin-induced damage in the rat small intestine. J Appl Toxicol 2007;27:551-560.
18. Sivalingam N, Basivireddy J, Balasubramanian KA, Jacob M. Curcumin attenuates indomethacin-induced oxidative stress and mitochondrial dysfunction. Arch Toxicol 2008;82:471-481.
19. Watanabe T, Higuchi K, Kobata A, Nishio H, Tanigawa T, Shiba M, et al. Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent. Gut 2008;57:181-187.
20. Stadnyk AW, Dollard C, Issekutz TB, Issekutz AC. Neutrophil migration into indomethacin induced rat small intestinal injury is CD11a/CD18 and CD11b/CD18 co-dependent. Gut 2002;50:629-635.
21. Tsuruma T, Yagihashi A, Tarumi K, Hirata K. Anti-rat IL-8 (CINC) monoclonal antibody administration reduces ischemiareperfusion injury in small intestine. Transplant Proc 1998;30:2644-2645.
22. Yagihashi A, Tsuruma T, Tarumi K, Kameshima T, Yajima T, Yanai Y, et al. Prevention of small intestinal ischemia-reperfusion injury in rat by anti-cytokine-induced neutrophil chemoattractant monoclonal antibody. J Surg Res 1998;78:92-96.
23. Shibata F. The role of rat cytokine-induced neutrophil chemoattractants (CINCs) in inflammation. Yakugaku Zasshi 2002;122:263-268.
24. Cenac N, Coelho AM, Nguyen C, Compton S, Andrade-Gordon P, MacNaughton WK, et al. Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2. Am J Pathol 2002;161:1903-1915.
25. Isozaki Y, Yoshida N, Kuroda M, Handa O, Takagi T, Kokura S, et al. Anti-tryptase treatment using nafamostat mesilate has a therapeutic effects on experimental colitis. Scand J Gastroenterol 2006;41:944-953.
26. Yoshida N, Isozaki Y, Takagi T, Takenaka S, Uchikawa R, Arizono N, et al. Review article: Anti-tryptase therapy in inflammatory bowel disease. Aliment Pharmacol Ther 2006;24(suppl 4):249-255.